Aetna published a positive coverage policy for the remedē System for eligible patients who meet certain criteria. Other insurance providers, including Medicare, may cover the remedē System on a case-by-case basis, with evidence of medical necessity. The Respicardia case management team can work with you on individual patient claims.

The Centers for Medicare and Medicaid Services (CMS) has approved the remedē System for the Transitional Pass-through (TPT) Payment for procedures performed in the outpatient setting and the New Technology Add-on Payment (NTAP) for procedures performed in the inpatient setting.

The Transitional Pass-through Payment and New Technology Add-on Payment are Medicare programs designed to supplement the payment for innovative medical technologies that substantially improve the diagnosis or treatment of a disease. The New Technology Add-on Payment became effective on October 1, 2018 and the Transitional Pass-through Payment became effective on January 1, 2019. The existence of pass-through payment status is not a guarantee of coverage.